DIOGENIX Trademark

Trademark Overview

On Wednesday, December 19, 2007, a trademark application was filed for DIOGENIX with the United States Patent and Trademark Office. The USPTO has given the DIOGENIX trademark a serial number of 77356139. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 3, 2020. This trademark is owned by Ore Pharmaceuticals Inc.. The DIOGENIX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

molecular diagnostic services, namely, research and development of non-invasive diagnostic, prognostic and disease progression and treatment response monitoring tests
diogenix

General Information

Serial Number77356139
Word MarkDIOGENIX
Filing DateWednesday, December 19, 2007
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 3, 2020
Registration Number3632393
Registration DateTuesday, June 2, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 16, 2008

Trademark Statements

Goods and Servicesmolecular diagnostic services, namely, research and development of non-invasive diagnostic, prognostic and disease progression and treatment response monitoring tests

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 3, 2020
Primary Code042
First Use Anywhere DateWednesday, April 30, 2008
First Use In Commerce DateWednesday, April 30, 2008

Trademark Owner History

Party NameDIOGENIX, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBethesda, MD 20814
Party NameDIOGENIX, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressGAITHERSBURG, MD 20878
Party NameDIOGENIX INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGAITHERSBURG, MD 20878
Party NameOre Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878

Trademark Events

Event DateEvent Description
Friday, January 3, 2020CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, June 2, 2018COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, December 30, 2014NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, December 30, 2014REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, December 30, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, December 9, 2014TEAS SECTION 8 & 15 RECEIVED
Sunday, July 14, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 2, 2009REGISTERED-PRINCIPAL REGISTER
Saturday, April 25, 2009LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, April 24, 2009ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, April 23, 2009STATEMENT OF USE PROCESSING COMPLETE
Friday, April 10, 2009USE AMENDMENT FILED
Thursday, April 23, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, April 10, 2009TEAS STATEMENT OF USE RECEIVED
Thursday, March 19, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 19, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 10, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 16, 2008PUBLISHED FOR OPPOSITION
Wednesday, November 26, 2008NOTICE OF PUBLICATION
Saturday, November 8, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, November 7, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 30, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 30, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 24, 2008ASSIGNED TO LIE
Wednesday, October 15, 2008AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, October 9, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 9, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 9, 2008NON-FINAL ACTION E-MAILED
Wednesday, April 9, 2008NON-FINAL ACTION WRITTEN
Tuesday, March 25, 2008ASSIGNED TO EXAMINER
Thursday, December 27, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

diogenix diagnostic treatment progression response monitoring tests disease invasive namely services